Infrastructure & Services

The Technologiepark Basel offers modern office space, and fully equipped, state of the art laboratories at favorable conditions

News

22.12.2021

Cellestia Biotech receives Orphan Drug Designation from the European Commission for CB-103 for the treatment of Acute Lymphoblastic Leukaemia

Where Science meets Business

The Technologiepark Basel is the premier address for early-stage tech start-ups in Basel. It offers a collaboration-friendly, yet business-driven environment and is part of the rapidly growing Stücki Park in the dynamic northern part of Basel. The Technologiepark Basel provides office space and fully equipped laboratories at highly favorable terms, and offers shared facilities and a variety of other services to tech start-ups.

Piqur Therapeutics: Moving on up, but staying close to the Technologiepark Basel

Richard Laube, Executive Chairman of Piqur Therapeutics

to the full story

Cellestia Biotech: A novel method from Basel to fight cancer

Michael Bauer, CEO Cellestia Biotech

to the full story

NBE Therapeutics: Cancer drugs with a twist for fewer side effects

Ulf Grawunder, NBE Therapeutics

to the full story

Artidis: Cancer diagnosis in less than 3 hours

Marija Plodinec, CEO of Artidis

to the story

Edelweiss Connect: Product safety with minimal animal testing

Barry Hardy, CEO of Edelweiss Connect

to the story

Interviews

Location

Companies